Loading...
Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)
BACKGROUND: The CRS-PRO is a new patient-reported outcome measure (PROM) for chronic rhinosinusitis (CRS) that was developed using extensive patient input per Food and Drug Administration guidance on PROMs acceptable for use as end points in clinical trials. OBJECTIVE: To assess the responsiveness a...
Na minha lista:
| Udgivet i: | J Allergy Clin Immunol Pract |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448959/ https://ncbi.nlm.nih.gov/pubmed/32361009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.04.031 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|